Showing results (101-110 of 196) with videos related to
Sort By:
Pageof 20
Gynecologic and Obstetric Investigation|January 1, 1993
Difference of the hormonal profile at the periovulatory phase in pregnant and nonpregnant cycles of infertile women with unexplained etiologyM Maegawa, M Kamada, M Takayanagi, et al.Journal of Perinatal Medicine|January 1, 1993
Pregnancy complicated by the May-Hegglin anomalyA Ishii, T Honnma, M Ishida, et al.Biological & Pharmaceutical Bulletin|March 8, 2000
Role of endogenous endotoxin on tumor necrosis factor-hypersensitivity caused by D-galactosamine challengeS Sakaguchi, S Furusawa, K Yokota, et al.Virology|September 1, 1993
Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infectionM Takayanagi, S Kakumu, T Ishikawa, et al.Hepatology (Baltimore, Md.)|August 1, 1993
Pilot study of ribavirin and interferon-beta for chronic hepatitis BS Kakumu, K Yoshioka, T Wakita, et al.Journal of Hepatology|November 1, 1995
Serum HCV RNA titer at the end of interferon therapy predicts the long-term outcome of treatmentT Aiyama, K Yoshioka, M Takayanagi, et al.Journal of Human Genetics|November 26, 1999
An Ile/Val polymorphism at codon 1464 of the ATP7A geneA Ogawa, S Yamamoto, M Takayanagi, et al.Pharmacology & Toxicology|November 1, 1996
The enhancing effect of tumour necrosis factor-alpha on oxidative stress in endotoxemiaS Sakaguchi, S Furusawa, K Yokota, et al.Biological & Pharmaceutical Bulletin|November 1, 1996
Effects of antitumor activity and protection of shock symptoms by a traditional Chinese medicine (sho-saiko-to) in recombinant human tumor necrosis factor administered miceS Sakaguchi, S Furusawa, K Yokota, et al.Haemostasis|January 1, 1991
Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markersT Inomoto, M Takamoto, R Tamura, et al.Pageof 20